L'apport thérapeutique des approches protéomiques dans les cancers

Translated title of the contribution: The therapeutic contribution of proteomic approaches in cancers

B. Hamrita, H. B. Nasr, M. Kabbage, P. Hamann, L. Kuhn, C. Guillier, S. Remadi, A. Chaieb, H. Khairi, L. Chouchane, K. Chahed

Research output: Contribution to journalArticle


Up to now, there are no protein tumor markers with a specificity and sensitivity sufficient to have a utility in prognosis and early diagnosis of cancer. Recent advances in proteomics approaches have led to the identification of novel tumor markers of cancer that may have a utility in screening strategies and treatment. The purpose of the current review is to describe the major advances in cancer proteomics, especially those related to the study of serum biomarkers, immune-related responses (autoantibodies) and alterations in cellular proteins.

Original languageFrench
Pages (from-to)87-93
Number of pages7
JournalGynecologie Obstetrique et Fertilite
Issue number2
Publication statusPublished - Feb 2011



  • Proteomics
  • Therapeutic targets
  • Tumors markers
  • Two dimensional gel electrophoresis

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Hamrita, B., Nasr, H. B., Kabbage, M., Hamann, P., Kuhn, L., Guillier, C., Remadi, S., Chaieb, A., Khairi, H., Chouchane, L., & Chahed, K. (2011). L'apport thérapeutique des approches protéomiques dans les cancers. Gynecologie Obstetrique et Fertilite, 39(2), 87-93. https://doi.org/10.1016/j.gyobfe.2010.12.005